We are live on ! Find out more

1,619 hedge funds and large institutions have $126B invested in Merck in 2014 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 602 increasing their positions, 699 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 53

5% more funds holding in top 10

Funds holding in top 10: 140147 (+7)

0% more call options, than puts

Call options by funds: $950M | Put options by funds: $950M

0% less funds holding

Funds holding: 1,6211,619 (-2)

1% less capital invested

Capital invested by funds: $127B → $126B (-$978M)

1.04% less ownership

Funds ownership: 78.25%77.21% (-1%)

14% less repeat investments, than reductions

Existing positions increased: 602 | Existing positions reduced: 699

Holders
1,619
Holders Change
-2
Holders Change %
-0.12%
% of All Funds
46.95%
Holding in Top 10
147
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+5%
% of All Funds
4.26%
New
65
Increased
602
Reduced
699
Closed
53
Calls
$950M
Puts
$950M
Net Calls
+$352K
Net Calls Change
-$100M
Name Holding Trade Value Shares
Change
Change in
Stake
CIM
451
Contravisory Investment Management
Massachusetts
$11.4M +$11.3M +201,117 New
TH
452
TCTC Holdings
Texas
$11.3M +$20.9K +372 +0.2%
LTFS
453
Ladenburg Thalmann Financial Services
Florida
$11.3M +$2.26M +40,230 +25%
BCM
454
Beddow Capital Management
Wyoming
$11.3M -$194K -3,459 -2%
NAM
455
North American Management
Massachusetts
$11.3M -$161K -2,872 -1%
FCI
456
Financial Counselors Inc
Kansas
$11.3M +$190K +3,391 +2%
PHS
457
PFM Health Sciences
California
$11.2M +$11.2M +198,816 New
SAM
458
Strategy Asset Managers
California
$11.2M +$70.6K +1,258 +0.6%
SCA
459
Stillwater Capital Advisors
Pennsylvania
$11.2M -$2.86K -51 -0%
FPCM
460
Financial Partners Capital Management
New York
$11.1M -$203K -3,612 -2%
PDN
461
Pensionfund DSM Netherlands
Netherlands
$11.1M
CI
462
Capital International
California
$11M +$2.22M +39,510 +25%
V
463
Veritable
Delaware
$11M +$37.4K +666 +0.3%
MCM
464
Monarch Capital Management
Indiana
$10.8M -$226K -4,024 -2%
RSCM
465
Rail-Splitter Capital Management
Illinois
$10.8M +$2.85M +50,720 +36%
KB
466
Kimelman & Baird
New York
$10.8M
WAM
467
Winslow Asset Management
Ohio
$10.8M +$56.9K +1,013 +0.5%
ABC
468
Associated Banc-Corp
Wisconsin
$10.8M +$76.3K +1,359 +0.7%
PFC
469
Phocas Financial Corp
California
$10.8M +$73.4K +1,307 +0.7%
Jones Financial Companies
470
Jones Financial Companies
Missouri
$10.8M +$704K +12,541 +7%
CA
471
Cullinan Associates
Kentucky
$10.6M +$1.93M +34,411 +22%
CCMG
472
Clark Capital Management Group
Pennsylvania
$10.6M +$2.77M +49,404 +36%
First Manhattan
473
First Manhattan
New York
$10.5M +$66.6K +1,186 +0.6%
TSW
474
Thompson Siegel & Walmsley
Virginia
$10.5M -$2.27M -40,444 -18%
PL
475
Parthenon LLC
Kentucky
$10.5M -$2.02K -36 -0%

MRK Hedge Fund Activity: Q3 2014 in Review

1,619 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2014, worth a combined $126B — down 0.77% from $127B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new MRK positions and 53 closed out — a net gain of 12 holders — while 602 added to existing stakes and 699 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $434M. The largest seller was Norges Bank, cutting an estimated $1.3B.

  • 1,619 institutional investors held Merck (MRK) as of Q3 2014, down from 1,621 in Q2 2014.
  • Funds reported $126B of Merck stock for Q3 2014, down 0.77% quarter-over-quarter.
  • 65 funds opened new Merck positions in Q3 2014 and 53 closed out, a net change of +12 holders.
  • The largest Merck buyer in Q3 2014 was JP Morgan Chase, an estimated $434M added.
  • The largest Merck seller in Q3 2014 was Norges Bank, an estimated $1.3B sold.

Based on aggregated 13F filings for Q3 2014.